Bright Minds Biosciences Inc. (DRUG:NASDAQ) rocketted at $1.98, a gain of 48.9%. On Wed, Aug 24, 2022, DRUG:NASDAQ touched a New 2-Week Intraday High of $2.6. From Wed, Aug 10, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Aug 18, 2022 at $4.75 with a volume of 119M+.
About Bright Minds Biosciences Inc. (DRUG:NASDAQ)
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
Top 10 Gainers:
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 66.52%
- SuperCom Ltd. (SPCB:NASDAQ), 62.36%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 48.87%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 37.9%
- Riverview Acquisition Corp. (RVAC:NASDAQ), 34.86%
- Gravitas Education Holdings Inc ADR (GEHI:NYSE), 24.83%
- Turquoise Hill Resources Ltd. (TRQ:NYSE), 23.76%
- Golden Sun Education Group Limited (GSUN:NASDAQ), 22.83%
- Farfetch Limited (FTCH:NYSE), 21.3%